Osteosarcoma

+ -Text Size

Other Resources and References TOPICS

References: Osteosarcoma detailed guide

American Cancer Society. Cancer Facts & Figures 2014. Atlanta, Ga. American Cancer Society; 2014.

Anderson ME, Randall RL, Springfield DS, Gebhart MC. Chapter 92: Sarcomas of bone. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014.

Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012;87:475–487.

Bielack S, Carrle D, Casali PG, ESMO Guidelines Working Group. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 Suppl 4:137–139.

Bielack SS, Carrle D. State-of-the-art approach in selective curable tumors: Bone sarcoma. Ann Oncol. 2008;19 Suppl 7:vii155-vii160.

Chou AJ, Bell MD, Mackinson C, et al. Phase Ib/IIa study of sustained release lipid inhalation targeting cisplatin by inhalation in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. J Clin Oncol. 2007;25(18s):9525.

Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007;459:40–47.

Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Chapter 95: Pediatric solid tumors. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014.Geller DS, Gorlick R. Osteosarcoma: A review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 2010;8:705–718.

Gorlick R, Bielack S, Teot L, Meyer J, Randall RL, Marina N. Osteosarcoma: Biology, diagnosis, treatment, and remaining challenges. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2011:1015–1044.

Gorlick R, Janeway K, Lessnick S, et al. Children’s Oncology Group’s 2013 blueprint for research: Bone tumors: COG Bone Tumor Committee. Pediatr Blood Cancer. 2013;60:1009–1015.

Grignani G1, Palmerini E, Dileo P, et al. A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian Sarcoma Group study. Ann Oncol. 2012;23:508–516.

Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget’s disease of bone. J Bone Miner Res. 2006;21 Suppl 2:P58–63.

Lewis DR, Ries LAG. Cancers of bone and joint. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Malawer MM, Helman LJ, O’Sullivan B. Sarcomas of bone. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 1578–1609.

Myers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival—a report from the Children’s Oncology Group. J Clin Oncol. 2008;26:633–638.

Nagarajan R, Neglia JP, Clohisy DR, Robison LL. Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: What are the long-term implications? J Clin Oncol. 2002;20:4493–4501.

National Cancer Institute Physician Data Query (PDQ). Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment. 2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/osteosarcoma/healthprofessional on March 5, 2014.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Bone Cancer. Version 1.2014. Accessed at www.nccn.org/professionals/physician_gls/pdf/bone.pdf on March 5, 2014.

Ottaviani G, Robert RS, Huh WW, Palla S, Jaffe N. Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents: Limb salvage versus amputation. Cancer. 2013;119:3727–3736.

Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999.

Roth M, Linkowski M, Tarim J, et al. Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer. 2014;120:548–554.

Wang LL, Yustein J, Louis C, et al. Solid tumors of childhood. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 1760–1792.

Yasko AW, Chow W, Haglund K. Bone sarcomas. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, eds. Cancer Management: A Multidisciplinary Approach. 13th ed. UBM Medica; 2010: 607–620.


Last Medical Review: 04/18/2014
Last Revised: 04/18/2014